Marburg virus vaccine safe in small, first-in-human clinical trial: NIH
A study published in the Lancet on January 28 shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. Read More
COVID-19 immune response strengthens over time
Oregon Health & Science University (OHSU) researchers found that the more time between vaccination and infection, the greater the strength of the immunity from COVID-19. The findings, published on Thursday in the Journal for Clinical Investigation Insight, suggest that people who’ve had COVID-19 can benefit from vaccination, even if they’ve delayed it. Read More
Grey Wolf Therapeutics nabs $49M in Series B financing
Grey Wolf Therapeutics, a biotech firm focused on generating antitumor immune responses through targeted cancer neoantigen creation, last week announced the closing of an oversubscribed $49 million Series B financing. Read More
Atomic AI closes $35M Series A financing
Biotech firm Atomic AI recently announced it the closing of a $35 million Series A round led by Playground Global, with participation from 8VC, Factory HQ, Greylock, NotBoring, AME Cloud Ventures, GitHub’s ex-CEO Nat Friedman, Doug Mohr, Curai CEO Neal Khosla, and UC Berkeley Professor and Arc Institute co-founder Patrick Hsu. Read More
EMR screening program identifies prevalent undiagnosed diabetes
An electronic medical record (EMR) diabetes screening program in an urban emergency department identified the prevalence of undiagnosed diabetes. The report, published on January 26 in JAMA Network Open, underscored long-existing disparities in type 2 diabetes diagnosis and treatment by race, ethnicity, and socioeconomic factors. Such disparities increased during the COVID-19 pandemic. Read More
Mixing cancer drugs in nanoparticle combinations improves efficacy in mice
Using polymer nanoparticles to carry multiple cancer drugs achieves better outcomes than administering the combination of therapeutics without a delivery vehicle, according to preclinical research published on 26 January in Nature Nanotechnology. Read More
AI tool makes speedy gene editing possible
Researchers have designed an artificial intelligence (AI) program that may enable the production of customizable proteins called zinc fingers to treat diseases by turning genes on and off. The research published on January 26 in Nature Biotechnology may accelerate large-scale gene therapy development. Read More
CVD deaths undergo largest single-year increase since 2015
The American Heart Association's report "Heart Disease and Stroke Statistics—2023 Update" outlines the most significant single-year increase in cardiovascular disease (CVD) deaths in the U.S. since 2015. Read More
Aston University partners with longevity biotech to advance lung disease treatment
Aston University's work on small molecule inhibitors of transglutaminase 2 has spawned a biotech firm focused on treating the chronic lung disease idiopathic pulmonary fibrosis. Read More
New probe measures cell stiffness and traction
University of Illinois scientists have developed a tiny mechanical probe that can measure the inherent stiffness of cells and tissues, as well as the internal forces that cells generate and exert upon one another. It is the first probe able to quantify both properties, according to its developers. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter